This study is for patients who have participated in a previous study and who continue to receive benefit to have continued access to study drug and/or treatment.
- To be eligible patients must be currently receiving benefit in a concluded Lilly study for a compound that has opened an addendum in the continued access protocol.
- Patients must not be concurrently enrolled in any other type of medical research judged not to be scientifically or medically compatible with this study.
Nashville, Tennessee, 37203
Investigator: There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT -5 hours, EST)
Eli Lilly and Company